Space Pharma: The Next Frontier in Biotechnology | Dr. Katie King - CEO, BioOrbit

本站添加: 2026-05-20

[00:00:00]and means that you can hit these different scales, you just run it for longer with more reagents coming in. And nothing like that has ever been done in space before. It's always been tiny tiny batches on the 1 ml scale. So, Baby Box is the It's called baby because it's the smallest in the family, but the Box platform is the first continuous production of protein crystals that's ever been done in space before. And we are hitting at least one order, if not two orders of magnitude larger than anything that's ever been done in space before. And this is a continuous flow reactor, and we will be crystallizing protein drugs in it. So, this mission is the first step towards mass manufacture, testing out that core technology, and we're really validating the system and demonstrating the control that we can have on these protein crystals on this scale, which for us is small, hence Baby Boxy, but compared to everything that's been done, it is orders of magnitude larger in scale.